News Clinical Trials Commence for First Adult TB Vaccine Derived from Human Source A new chapter in tuberculosis (TB) prevention has begun with the commencement of clinical trials for MTBVAC, the first adult TB vaccine developed from a human source.
News Bharat Biotech and Biofabri's TB Vaccine Candidate, MTBVAC, Enters Clinical Trials in India Bharat Biotech and Biofabri have begun clinical trials in India for MTBVAC, a new tuberculosis vaccine candidate derived from a human strain of Mycobacterium tuberculosis.
